Impact of bcr-abl1 transcript type on response, treatment-free remission rate and survival in chronic myeloid leukemia patients treated with imatinib

  1. Marcé, S.
  2. Xicoy, B.
  3. García, O.
  4. Cabezón, M.
  5. Estrada, N.
  6. Vélez, P.
  7. Boqué, C.
  8. Sagüés, M.
  9. Angona, A.
  10. Teruel-Montoya, R.
  11. Ferrer-Marín, F.
  12. Amat, P.
  13. Hernández-Boluda, J.C.
  14. Ibarra, M.M.
  15. Anguita, E.
  16. Cortés, M.
  17. Fernández-Ruiz, A.
  18. Fontanals, S.
  19. Zamora, L.
Revue:
Journal of Clinical Medicine

ISSN: 2077-0383

Année de publication: 2021

Volumen: 10

Número: 14

Type: Article

DOI: 10.3390/JCM10143146 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus